Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 486

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 5
Chunk 486
---
 agreement, pursuant to which they have agreed to (i) waive their redemption rights
with respect to any founder shares, private shares and public shares held by them in connection with the completion of the initial Business
Combination, (ii) waive their redemption rights with respect to any founder shares, private shares and public shares held by them
in connection with a shareholders’ vote to amend the amended and restated memorandum and articles of association (A) to modify
the substance or timing of the obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of
the public shares if the Company does not complete the initial Business Combination within the Combination Period (as defined below) or
(B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity;
and (iii) waive their rights to liquidating distributions from the trust account with respect to any founder shares and private shares
they hold if the Company fails to complete the initial Business Combination within the Combination Period (although they will be entitled
to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial
Business Combination within the Combination Period). If the Company submits the initial Business Combination to the public shareholders
for a vote, the initial shareholders, directors and officers have agreed (and their permitted transferees will agree), pursuant to the
terms of a letter agreement, to vote any shares held by them in favor of the initial Business Combination.

The underwriters have agreed to waive their rights
to their deferred underwriting commissions (see Note 6) held in the Trust Account in the event the Company does not complete a Business
Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account
that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share
value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00).

F-8

The Company will have until 15 months
from the closing of the Initial Public Offering to complete a Business Combination. However, if the Company is unable to complete the
initial Business Combination within 15 months from the closing the Initial Public Offering, the time period to complete an initial
Business Combination can be extended without shareholder approval up to two times, each by an additional three months